Shoulder Innovations (NYSE:SI) COO Sells $167,111.40 in Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 8,314 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $20.10, for a total transaction of $167,111.40. Following the sale, the chief operating officer directly owned 258,362 shares of the company’s stock, valued at $5,193,076.20. This represents a 3.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Tuesday, August 18th, Matthew Fraser Ahearn sold 14,186 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.99, for a total value of $297,764.14.
• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.84, for a total value of $78,072.96.
• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.68, for a total transaction of $296,190.08.

Shoulder Innovations Trading Down 5.7%

Shoulder Innovations stock opened at $21.94 on Friday. The company’s fifty day simple moving average is $20.88 and its 200-day simple moving average is $16.48. The company has a quick ratio of 8.92, a current ratio of 10.71 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The stock has a market cap of $456.77 million and a P/E ratio of -11.43.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, sell-side analysts forecast that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Compass Financial Management LLC bought a new position in shares of Shoulder Innovations in the second quarter valued at about $30,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Shoulder Innovations in the 3rd quarter valued at about $28,000. Rhumbline Advisers bought a new position in shares of Shoulder Innovations in the third quarter worth about $54,000. Wells Fargo & Company MN lifted its position in shares of Shoulder Innovations by 66.3% during the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after purchasing an additional 2,094 shares in the last quarter. Finally, Renaissance Technologies LLC acquired a new position in shares of Shoulder Innovations during the fourth quarter worth approximately $176,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. BTIG Research upped their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. UBS Group boosted their price objective on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Shoulder Innovations has a consensus rating of “Moderate Buy” and an average target price of $23.50.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.